LAVAL, Quebec, Nov. 10, 2016 /CNW/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced that Joseph C. Papa, Chairman and CEO, will participate in the following healthcare conferences:
- Stifel 2016 Healthcare Conference on Tuesday, November 15, 2016 at 8:00 a.m. ET at the New York Palace Hotel;
- Guggenheim 4th Annual Boston Healthcare Conference on Tuesday, December 13, 2016 at 11:45 a.m. ET at the Intercontinental Boston; and,
- BMO Prescriptions for Success Healthcare Conference on Wednesday, December 14, 2016 at 1:30 p.m. ET at the InterContinental Barclay Hotel in New York City.
A live webcast and audio archive of the events will be available on Valeant's Investor Relations website and via this URL: http://ir.valeant.com/investor-relations/events-and-presentations/default.aspx
Valeant Pharmaceuticals International, Inc. (NYSE/TSX:VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, gastrointestinal disorders, eye health, neurology and branded generics. More information about Valeant can be found at www.valeant.com.
877-281-6642 (toll free)
Chris Kittredge/Jared Levy
Sard Verbinnen & Co.
SOURCE Valeant Pharmaceuticals International, Inc.